Coronary Artery Disease, Stable Angina
Conditions
Keywords
Rotational atherectomy, Conventional stenting, CMD, Microcirculation, Index of microcirculatory resistance, IMRangio
Brief summary
The purpose of this observational study is to compare the impact of rotational atherectomy to conventional stenting and to investigate how it may affect coronary microcirculation in patients with calcified coronary artery lesions and stable CAD. The study's objectives are to: * investigate the impact of rotational atherectomy on the prevalence of post-percutaneuos coronary intervention coronay microvascular dysfunction; * investigate the impact of conventional stenting on the prevalence of post-percutaneuos coronary intervention coronay microvascular dysfunction; and * compare the impact of both percutaneuos coronary interventions on coronary microvascular dysfunction. Patients with calcified lesions will be enrolled prospectively and will have serial invasive and non-invasive microvascular testing prior to and after rotational atherectomy or conventional stenting.
Detailed description
Rotational atherectomy (RA) is a medical procedure used to treat patients with severe atherosclerosis, a condition that causes plaque buildup within the artery walls, resulting in narrowing of the blood vessels and decreased blood flow to the heart. RA is a technique that involves breaking up and removing plaque from the artery with a small, high-speed rotating burr. However, RA is not without risks. One of the major risks associated with RA is the potential damage to the artery wall and surrounding tissue. This can lead to complications such as bleeding, blood clots, or injury to the heart or other organs. Additionally, the high-speed rotation of the burr can generate heat, which may damage the artery wall or cause the release of harmful particles into the bloodstream. Another hypothesized risk of RA is its impact on microcirculation, which refers to the smallest blood vessels in the body. RA can cause disruption to these vessels, leading to a decrease in blood flow and potentially causing damage to tissues and organs that depend on them. The purpose of this study is to look into the effect of rotational atherectomy on coronary microcirculation.
Interventions
DIAGNOSTIC_TESTcoronary pressure/temperature sensor-tipped guidewire
In brief, a 6-F angioplasty guiding catheter without side-holes will be used first used to engage the left main coronary artery. A pressure-temperature sensor guidewire ( PressureWire™ X Guidewire) will be used for physiology measurements including IMR measurements. Pressure measurement from the wire will be first equalized with that of the guiding catheter. Then the pressure sensor will be positioned two-thirds of the way down the LAD artery. Intracoronary nitroglycerin will be administered (100 to 200 μg). Hyperemia will be induced with adenosine intracoronary injections.
DIAGNOSTIC_TESTAngiography-derived index of microcirculatory resistance (IMRangio)
Angiography-derived index of microcirculatory resistance (IMRangio) will be calculated by an anticipated software
Sponsors
Klaipėda University
Kreiskrankenhaus Rotenburg an der fluda
Alkafeel Super Speciality Hospital
Lithuanian University of Health Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Participants are randomly assigned to receive either the rotational atherectomy or conventional stenting alone.
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient diagnosed with stable coronary artery calcified lesion requiring Percutaneous coronary intervention
Exclusion criteria
* patients with a history of old myocardial infarction or history of coronary artery bypass grafting (CABG) or Percutaneous coronary intervention PCI * Patients with signs of chronic infection, prolong usage of corticosteroids or compromised immune system * patients had contraindication of adenosine triphosphate (ATP); * had a history of liver or renal function dysfunction * Patients with dementia * Patients being referred to CABG * unable to provide informed consent; * had pregnancy or life span \< 1 year. * Presence of sever structural valvular heart disease * Presence of significant left main disease * Unability to measure the index of microcirculatory resistance due to (death or retraction from the study ...etc) * Inability to perform successful PCI
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The incidence of coronary microvascular dysfunction | 1 day | Microcirculatory dysfunction will be defined as having an IMR value ≥ 25 U and a CFR value \< 2.5 U or angio IMR ≥ 25 U |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Seattle Angina Questionnaire score | 1 year | Evaluates the severity of angina symptoms, physical limitations, and quality of life |
| The incidence of coronary microvascular dysfunction | 1 year | Microcirculatory dysfunction will be defined as having an IMR value ≥ 25 U and a CFR value \< 2.5 U or angio IMR ≥ 25 U |
| Rate of Major adverse cardiovascular events | 1 year | composite of nonfatal stroke, nonfatal myocardial infarction, heart failure, target vessel revascularization and cardiovascular death. |
Countries
Lithuania
Contacts
Primary ContactAli Aldujeli
Outcome results
None listed